In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By



Latest From PharMerica

Nursing Home Overprescribing: Pharmacist Independence Requirement Should Start As Demo, APhA Says

CMS’ proposal to reduce overprescribing in nursing homes draws cautiously favorable response from national pharmacist group, but long-term care pharmacy firm Omnicare argues the agency has not provided adequate justification for its plan.


Bergen Brunswig Gets Out Of the Specialty Retail Business

Bergen Brunswig Corp's recent announcement that it would sell the specialty pharmacy assets of its Stadtlander Drug Co. subsidiary hardly comes as a surprise. Stadtlander has performed poorly since it was acquired from Counsel Corp. eighteen months ago. Stadtlander is not alone: two other Bergen subsidiaries, PharMerica (which distributes drugs to long-term care facilities) and Bergen Brunswig Medical Corp., a supply business (which is also being sold), have also disappointed.If Bergen's expectations for Stadtlander were not met, say company officials, it was because Counsel's management misled them with respect to the specialty pharmacy's value. Indeed, Bergen sued Counsel, alleging that it was fraudulently induced into paying the price that it did for Stadtlander. That case is pending.So far, investors and analysts have reacted favorably to the Stadtlander sale. In addition to reducing Bergen's debt and eliminating a drag on earnings, parting with Stadtlander is seen as a way for Bergen to refocus its attentions on its core drug distribution business.
BioPharmaceutical Medical Device

Bergen Brunswig's Long-Term Play

With its recent merger with PharMerica Inc., the country's largest supplier of pharmaceuticals to long-term care providers, Bergen Brunswig corp. has taken what appears to be the most traditional alternative of the three leading drug wholesalers.
Medical Device Business Strategies
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Services
    • Pharmacy Services, PBMs
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PharMerica
  • Senior Management
  • Greg Weishar, CEO
    Robert E Dries, EVP, CFO
    Bernard Tomassetti, EVP, Chief Accounting Officer
  • Contact Info
  • PharMerica
    Phone: (866) 209-2178
    1901 Campus Place
    Louisville, KY 40299